On the path towards universal coverage of hepatitis C treatment among people receiving opioid agonist therapy (OAT) in Norway: a prospective cohort study from 2013 to 2017

On the path towards universal coverage of hepatitis C treatment among people receiving opioid agonist therapy (OAT) in Norway: a prospective cohort study from 2013 to 2017

Objectives We aimed to calculate cumulative hepatitis C virus (HCV) treatment coverage among individuals enrolled in opioid agonist therapy (OAT) in Norway between 2013 and 2017 and to document the treatment transition to direct-acting antiviral (DAA) agents. Moreover, we aimed to describe adherence...

Full description

Saved in:
Bibliographic Details
Main Authors: Peter Vickerman, Ingvild Odsbu, Kjell Arne Johansson, Jørn Henrik Vold, Svetlana Skurtveit, Fatemeh Chalabianloo, Christer Frode Aas, Jan Magnus Økland, Rafael Alexander Modahl Leiva, Lars T Fadnes
Format: Article
Language:English
Published: BMJ Publishing Group 2020-08-01
Series:BMJ Open
Online Access:https://bmjopen.bmj.com/content/10/8/e036355.full
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://bmjopen.bmj.com/content/10/8/e036355.full

Similar Items